InMed Pharmaceuticals Inc Share Price Canadian Securities Exchange
Equities
IN
CA4576371062
Biotechnology & Medical Research
Sales 2024 * | 7.3M 5.33M 425M | Sales 2025 * | 9.12M 6.66M 531M | Capitalization | 2.01M 1.46M 117M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.27 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.22 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.64% |
Latest transcript on InMed Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 15/06/16 |
Chief Operating Officer | - | 04/11/18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 10/02/22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 15/06/16 |
Andrew Hull
CHM | Chairman | 61 | 11/09/16 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |